We are hereby Submitting Disclosure under Regulation 29(1) of SEBI(SAS&T) Regulation, 2011
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sharp Eye Medicare Private Limited has disclosed a first-time acquisition of 28,57,142 equity shares (face value Rs. 10) in Sharpline Broadcast Limited, equal to 9.98% of the paid-up share capital. The shares were allotted on a preferential basis on February 24, 2026, pursuant to conversion of a loan. The acquisition has pushed Sharp Eye Medicare's holding from 0% to 9.98%, crossing the 5% disclosure threshold. The acquirer is not part of the promoter/promoter group. The company's equity share capital increased from 1,67,77,776 shares to 2,86,34,916 shares as a result of this allotment.
A new non-promoter entity now holds nearly 10% of Sharpline Broadcast, sitting just below the next regulatory disclosure trigger. Shareholders should watch for any further acquisitions by Sharp Eye Medicare, and note that the preferential allotment signals the company has raised equity from a strategic investor rather than via the open market.